Acorah Software Products - Accounts Production 16.8.310 false true true 30 April 2024 1 May 2023 false 14 January 2026 true 1 May 2024 30 April 2025 30 April 2025 01718460 Ms D Kettle Miss C Santucci Mr Peter Seldon iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 01718460 2024-04-30 01718460 2025-04-30 01718460 2024-05-01 2025-04-30 01718460 frs-core:CurrentFinancialInstruments 2025-04-30 01718460 frs-core:FurnitureFittings 2025-04-30 01718460 frs-core:FurnitureFittings 2024-05-01 2025-04-30 01718460 frs-core:FurnitureFittings 2024-04-30 01718460 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2025-04-30 01718460 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-05-01 2025-04-30 01718460 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2024-04-30 01718460 frs-core:MotorVehicles 2025-04-30 01718460 frs-core:MotorVehicles 2024-05-01 2025-04-30 01718460 frs-core:MotorVehicles 2024-04-30 01718460 frs-core:CapitalRedemptionReserve 2025-04-30 01718460 frs-core:ShareCapital 2025-04-30 01718460 frs-core:RetainedEarningsAccumulatedLosses 2024-05-01 2025-04-30 01718460 frs-core:RetainedEarningsAccumulatedLosses 2025-04-30 01718460 frs-bus:HighestPaidDirector 2024-05-01 2025-04-30 01718460 frs-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 01718460 frs-bus:FullAccounts 2024-05-01 2025-04-30 01718460 frs-bus:MediumEntities 2024-05-01 2025-04-30 01718460 frs-bus:Audited 2024-05-01 2025-04-30 01718460 frs-bus:Medium-sizedCompaniesRegimeForAccounts 2024-05-01 2025-04-30 01718460 frs-bus:Medium-sizedCompaniesRegimeForDirectorsReport 2024-05-01 2025-04-30 01718460 frs-bus:OrdinaryShareClass1 2024-05-01 2025-04-30 01718460 frs-bus:OrdinaryShareClass1 2025-04-30 01718460 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2025-04-30 01718460 frs-core:ListedExchangeTraded 2025-04-30 01718460 frs-core:ListedExchangeTraded 2024-04-30 01718460 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-04-30 01718460 frs-core:DisposalsRepaymentsInvestments frs-core:ListedExchangeTraded 2025-04-30 01718460 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-04-30 01718460 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-04-30 01718460 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-04-30 01718460 frs-bus:Director1 2024-05-01 2025-04-30 01718460 frs-bus:Director1 2024-04-30 01718460 frs-bus:Director1 2025-04-30 01718460 frs-bus:Director2 2024-05-01 2025-04-30 01718460 frs-bus:Director3 2024-05-01 2025-04-30 01718460 1 2024-05-01 2025-04-30 01718460 3 2024-05-01 2025-04-30 01718460 frs-countries:EnglandWales 2024-05-01 2025-04-30 01718460 2023-04-30 01718460 2024-04-30 01718460 2023-05-01 2024-04-30 01718460 frs-core:CurrentFinancialInstruments 2024-04-30 01718460 frs-core:CapitalRedemptionReserve 2023-04-30 01718460 frs-core:CapitalRedemptionReserve 2024-04-30 01718460 frs-core:ShareCapital 2023-04-30 01718460 frs-core:ShareCapital 2024-04-30 01718460 frs-core:RetainedEarningsAccumulatedLosses 2023-05-01 2024-04-30 01718460 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2023-04-30 01718460 frs-core:RetainedEarningsAccumulatedLosses 2024-04-30 01718460 frs-bus:HighestPaidDirector 2023-05-01 2024-04-30 01718460 frs-bus:OrdinaryShareClass1 2023-05-01 2024-04-30 01718460 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2023-04-30 01718460 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2024-04-30 01718460 1 2023-05-01 2024-04-30 01718460 3 2023-05-01 2024-04-30
Registered number: 01718460
Consultus Care and Nursing Ltd
Strategic Report, Directors' Report and
Financial Statements
For The Year Ended 30 April 2025
Tony Levy Associates
Contents
Page
Strategic Report 1—3
Directors' Report 4—5
Independent Auditor's Report 6—9
Profit and Loss Account 10
Statement of Comprehensive Income 11
Balance Sheet 12—13
Statement of Changes in Equity 14
Statement of Cash Flows 15
Notes to the Statement of Cash Flows 16
Notes to the Financial Statements 17—25
Page 1
Strategic Report
The directors present their strategic report for the year ended 30 April 2025.
Review of the Business
For well over 60 years, Consultus Care and Nursing has been a trusted nationwide provider of exceptional live-in-care, and live-in nursing services – 24/7 across the United Kingdom. 
We remain a family owned, family run 24/7 live in care and nursing company for families.   
Our established reputation for delivering high-quality care, and nursing has been built on enabling our clients to live safely and independently in the comfort and the familiarity of their own homes which research unsurprisingly confirms most older people would prefer to stay. 
With our diverse range of live-in care services, we ensure that older people can remain in their own homes throughout their later years, eliminating the need to ever move into a care or nursing home institution.
From companionship, to supporting complex medical conditions, like dementia and Parkinson's through to nursing and end-of-life care, we support individuals throughout their journey as needs change and evolve. Everything we do is driven by our passion to provide a quality service that makes a true difference to our client's lives, whilst enhancing independence and enriching well-being. 
Our reputation is built on trust and excellence since our foundation in 1962.  Client family recommendations have driven our growth. In 2024/25 89% of new clients have come from recommendations :  testament to the quality of care we deliver across all our services. 
Consultus Care & Nursing review rated by www.homecare.co.uk 9.8 out of ten.
Principal Risks and Uncertainties
By providing the skills required in an increasing competitive market, our inhouse Skills for Care award-winning 'Centre Of Excellence' training centre attracts suitable candidates with the necessary combination of capability and empathy, and equips them to provide personalised, tailored care geared to the individual need of our clients.  
The Company mitigates the risk of losing these carers by supporting them as much as we can, and especially that from our managed local care consultants based across half the country - with plans to further extend this coverage as quickly as possible. And also by updating them with the latest care courses as they become available up to Diploma level, and with other specialist qualifications. 
Consultus offers, uniquely three 24/7 live-in-services: from our introductory live-in care service :  ideal for families who wish to remain and can remain closely involved in overseeing their families' care - to our fully managed CQC regulated live-in care service, to specialist nursing care at home, we offer highly tailored services to meet individuals' unique needs. This provides much-needed choice and flexibility. 
Every carer, whether working independently for our introductory service or whilst they are in placement delivering managed care, must complete our market leading induction training programme, endorsed by Skills for Care as a 'Centre of Excellence'. On-going training and professional development are required for all carers working for us, or through us, including specialist training in conditions like dementia and Parkinson's. Unlike other agencies, new carers working for our introductory service must complete 12-weeks of placement with our managed service. This enables them to be effectively on-boarded by one of a Regional Care Consultants who monitor and manage the care they provide, helping to support and embed new learnings. We are then confident they have the skills and aptitude to deliver high-quality care before they work in an introductory placement.
Consultus continues to invest in recruitment in the UK and overseas, to attract and train suitable candidates. There has been an on-going shortage of skilled carers and meeting the increasing demand for our service has sometimes been challenging. We continue to review our marketing strategy to attract and retain suitable, empathetic, and capable professional carers and nurses. 
...CONTINUED
Page 1
Page 2
Principal Risks and Uncertainties - continued
We are also continuing to heavily invest in developing our own technology and resources, with careful planning, and with new ways of working and connecting people with our in-house bespoke family 'Connect App' providing real time information of, and about the care delivered. We are also carefully deploying AI where it can genuinely add value for all parties.
Development and performance
2025 has seen us review our strategic goals with a focus on further strengthening the quality of care we provide. Whilst we strongly believe families should be provided with choice over how their care arrangement is managed, we have aligned our business to focus three unique services to effectively meet client needs. This has seen the streamlining of our processes, integration of teams across the business, new investment in key roles in quality, sales, and marketing and expanding our senior management leadership team.
We are immensely proud of our commitment to investing in our own tailored inhouse systems and apps, to continually improve the care our clients receive, without being held back by third party product limitations. Our 'Connect' App first launched in 2020 has revolutionised how we deliver and monitor care. By continually evolving this platform, we ensure it remains a robust, user-friendly tool that enhances transparency and quality of care. Families, and especially extended families can feel connected and informed about as to their loved one's care, while carers are empowered with the tools to excel in their roles. 
To reduce the administration burden associated with carer applications, we have also streamlined the Consultus recruitment application process, whilst improving the online experience through significant enhancements to our 'Connect App'. At the point of application we request all right-to-work checks which are uploaded to the portal, which facilitates a seamless application journey, significantly reducing ineligible applications. 
Page 2
Page 3
Key performance indicators
  • Steady growth of the introductory service.
  • Significant growth of the managed care service.
  • Providing continued high calibre, trained carers.
  • Providing high calibre nurses.
  • Sustaining Consultus value including empathy, integrity, compassion, professionalism, experience and continue provision of a range of services tailored to suit clients' specific needs. 
The main KP used by the company are as follows:
  • Gross Profit percentange 55% (YR 2024: 57%)
  • Net Profit percentage (before tax) 19% (YR 2024: 24%)
  • Decrease in Turnover 3% (YR 2024: Increase in turnover - 8%)
  • Current Ratio 4.45 (YR2024: 7.57)
These are all considered to be satisfactory by the directors
On behalf of the board
Mr Peter Seldon
Director
9 January 2026
Page 3
Page 4
Directors' Report
The directors present their report and the financial statements for the year ended 30 April 2025.
Principal Activity
The principal activity of the company continues to be that of proprietors and operators of an agency providing three distinctive services:
· The provision of introduced self-employed carers
· The provision of managed care services
· The provision of managed nursing services
Directors
The directors who held office during the year were as follows:
Ms D Kettle
Miss C Santucci
Mr Peter Seldon
Statement of Directors' Responsibilities
The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards, comprising FRS102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing the financial statements the directors are required to:
  • select suitable accounting policies and then apply them consistently;
  • make judgments and accounting estimates that are reasonable and prudent;
  • state whether applicable United Kingdom Accounting Standards, comprising FRS102, have been followed subject to any material departures disclosed and explained in the financial statements;
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Page 4
Page 5
Statement of Disclosure of Information to Auditors
In the case of each director in office at the date the Directors' Report is approved:
  • so far as the director is aware, there is no relevant audit information of which the company's auditors are unaware; and
  • they have taken all the steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information.
Independent Auditors
The auditors, Tony Levy Management, have indicated their willingness to continue in office and a resolution concerning their re-appointment will be proposed at the Annual General Meeting.
On behalf of the board
Mr Peter Seldon
Director
9 January 2026
Page 5
Page 6
Independent Auditor's Report
Opinion
We have audited the financial statements of Consultus Care and Nursing Ltd for the year ended 30 April 2025 which comprise the Profit and Loss Account, Statement of Comprehensive Income, Balance Sheet, Statement of Changes of Equity, Cash Flow Statement and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
In our opinion the financial statements:
  • give a true and fair view of the state of the company's affairs as at 30 April 2025 and of its profit/(loss) for the year then ended;
  • have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
  • have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions Relating to Going Concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the entity's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other Information
The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Page 6
Page 7
Opinions on Other Matters Prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
  • the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
  • the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.
Matters on Which We Are Required to Report by Exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
  • adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
  • the financial statements are not in agreement with the accounting records or returns; or
  • certain disclosures of directors' remuneration specified by law are not made; or
  • we have not received all the information and explanations we require for our audit.
Responsibilities of Directors
As explained more fully in the Directors' Responsibilities Statement set out on page 4—5, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Page 7
Page 8
Auditor's Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: 
  • Enquire of management about the company's policies, procedures and related controls regarding compliance with laws and regulations and if there are any known instances of non-compliances;
  • Examining supporting documents for all material balances, transactions and disclosures;
  • Review of the Board of directors minutes;
  • Evaluation of the section and application of accounting policies related to subjective measurements and complex transactions;
  • Analytical procedures to identify any unusual or expected relationships
  • Testing the appropriateness of journal entries recorded in the general ledger and other adjustments made in the preparation of the financial statements;
  • Evaluation of the overall presentation, structure and content of the financial statements including accounting estimates and disclosures and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
Owing to the inherent limitations of an audit, there is unavoidable risk that some material misstatement of the financial statements may not be detected, even though the audit is properly planning and performed in accordance with the ISA (UK).
The potential effect of inherent limitations are particularly significant in the case of misstatement resulting from fraud because fraud may involve sophisticated an carefully organised schemes designed to conceal it, including deliberate failure to report transacstions, collusion or intentional misrepresentation being made to us. 
We design our procedures so as to obtain sufficient appropriate audit evidence that the financial statements are not materially misstated due to non-compliance with laws and regulations or due to fraud or error. 
We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations - this responsibility lies with the management with the oversight to the directors. 
Based on our understanding of the company and industry and discussions with management, we identified financial reporting standards and Companies Act 2006 as having a direct effect on the amounts and disclosures in the financial statements. 
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Use Of Our Report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters that we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Page 8
Page 9
Philip Horesh (Senior Statutory Auditor)
for and on behalf of Tony Levy Management , Statutory Auditor
14 January 2026
Tony Levy Management
Chartered Accountants & Registered Auditors
First Floor, 314 Regents Park Road
Finchley
London
N3 2LT
Page 9
Page 10
Profit and Loss Account
2025 2024
Notes £ £
TURNOVER 9,925,595 10,266,038
Cost of sales (4,500,590 ) (4,442,672 )
GROSS PROFIT 5,425,005 5,823,366
Administrative expenses (3,799,539 ) (3,695,168 )
Other operating income 101,640 109,147
OPERATING PROFIT 4 1,727,106 2,237,345
Fair value gains on investments 12,683 23,574
Profit on disposal of fixed asset investments 24,622 -
Other interest receivable and similar income 9 107,945 161,806
Interest payable and similar charges 10 (52 ) (4,260 )
PROFIT BEFORE TAXATION 1,872,304 2,418,465
Tax on Profit 11 (457,884 ) (590,082 )
PROFIT AFTER TAXATION BEING PROFIT FOR THE FINANCIAL YEAR 1,414,420 1,828,383
The notes on pages 16 to 25 form part of these financial statements.
Page 10
Page 11
Statement of Comprehensive Income
2025 2024
£ £
PROFIT FOR THE FINANCIAL YEAR 1,414,420 1,828,383
OTHER COMPREHENSIVE INCOME FOR THE YEAR - -
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 1,414,420 1,828,383
Page 11
Page 12
Balance Sheet
Registered number: 01718460
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 12 5,531,609 3,994,545
Investments 13 - 247,729
5,531,609 4,242,274
CURRENT ASSETS
Debtors 14 483,511 371,024
Cash at bank and in hand 2,943,361 5,480,734
3,426,872 5,851,758
Creditors: Amounts Falling Due Within One Year 15 (769,498 ) (775,843 )
NET CURRENT ASSETS (LIABILITIES) 2,657,374 5,075,915
TOTAL ASSETS LESS CURRENT LIABILITIES 8,188,983 9,318,189
PROVISIONS FOR LIABILITIES
Deferred Taxation 16 - (30,943 )
NET ASSETS 8,188,983 9,287,246
CAPITAL AND RESERVES
Called up share capital 17 247,152 247,152
Capital redemption reserve 10,300 10,300
Fair value reserve - 12,683
Profit and Loss Account 7,931,531 9,017,111
SHAREHOLDERS' FUNDS 8,188,983 9,287,246
Page 12
Page 13
On behalf of the board
Mr Peter Seldon
Director
9 January 2026
The notes on pages 16 to 25 form part of these financial statements.
Page 13
Page 14
Statement of Changes in Equity
Share Capital Capital Redemption Fair value reserve Profit and Loss Account Total
£ £ £ £ £
As at 1 May 2023 247,152 10,300 12,683 7,788,728 8,058,863
Profit for the year and total comprehensive income - - - 1,828,383 1,828,383
Dividends paid - - - (600,000) (600,000)
As at 30 April 2024 and 1 May 2024 247,152 10,300 12,683 9,017,111 9,287,246
Profit for the year and total comprehensive income - - - 1,414,420 1,414,420
Dividends paid - - - (2,500,000) (2,500,000)
Movements in fair value reserve - - (12,683) - (12,683)
As at 30 April 2025 247,152 10,300 - 7,931,531 8,188,983
Page 14
Page 15
Statement of Cash Flows
2025 2024
Notes £ £
Cash flows from operating activities
Net cash generated from operations 1 1,924,191 2,451,953
Interest paid (52 ) (4,260 )
Tax paid (648,948 ) (616,740 )
Net cash generated from operating activities 1,275,191 1,830,953
Cash flows from investing activities
Purchase of tangible assets (1,692,860 ) (118,478 )
Proceeds from disposal of other fixed asset investments 272,351 -
Interest received 107,945 161,806
Net cash (used in)/generated from investing activities (1,312,564 ) 43,328
Cash flows from financing activities
Equity dividends paid (2,500,000 ) (600,000 )
Amount introduced by directors 1,143 -
Amount withdrawn by directors (1,143) (1,143)
Net cash used in financing activities (2,500,000 ) (601,143 )
(Decrease)/increase in cash and cash equivalents (2,537,373 ) 1,273,138
Cash and cash equivalents at beginning of year 2 5,480,734 4,207,596
Cash and cash equivalents at end of year 2 2,943,361 5,480,734
Page 15
Page 16
Notes to the Statement of Cash Flows
1. Reconciliation of profit for the financial year to cash generated from operations
2025 2024
£ £
Profit for the financial year 1,414,420 1,828,383
Adjustments for:
Tax on profit 457,884 590,082
Interest expense 52 4,260
Interest income (107,945 ) (161,806 )
Depreciation of tangible assets 155,796 126,539
Profit on disposal of fixed asset investments (24,622) -
Net fair value gains recognised in profit or loss (12,683) (23,574)
Movements in working capital:
(Increase)/decrease in trade and other debtors (112,487 ) 201,864
Increase/(decrease) in trade and other creditors 153,776 (113,795 )
Net cash generated from operations 1,924,191 2,451,953
2. Cash and cash equivalents
Cash and cash equivalents, as stated in the Statement of Cash Flows, relates to the following items in the Balance Sheet:
2025 2024
£ £
Cash at bank and in hand 2,943,361 5,480,734
3. Analysis of changes in net funds
As at 1 May 2024 Cash flows As at 30 April 2025
£ £ £
Cash at bank and in hand 5,480,734 (2,537,373) 2,943,361
Page 16
Page 17
Notes to the Financial Statements
1. General Information
Consultus Care and Nursing Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 01718460 . The registered office is 17 London Road, Tonbridge, Kent, TN10 3AB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.
2.3. Significant judgements and estimations
Preparation of the financial statements requires management to make significant judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the statement of financial position date and the amounts reported for revenues and expenses during the period. However, the nature of estimation means that actual outcomes could differ from those estimates.
There were no judgements and estimations used in the financial statements apart from the depreciation charges and fair value adjustment of investments. 
2.4. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.5. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold Nil
Motor Vehicles 25% Reducing Balance
Fixtures & Fittings 25 & 33.3% Reducing Balance
2.6. Investments
Interests in entities are in listed investments measured at fair value. The investments are measured at fair value and any movement in fair value are recognised immediately in profit or loss.
Page 17
Page 18
2.7. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.8. Financial Instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instrument Issues' of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. 
Financial assets and liabilities are offset with the net amounts presented in the financial statements, when there is a legally enforeceable right to sell off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. 
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs. 
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, whic is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment. 
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date. 
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. 
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price. 
Trade creditors are obligations to pay for goods or service that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price. 
Other financial liabilities
...CONTINUED
Page 18
Page 19
2.8. Financial Instruments - continued
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date derivative contract is entered into and are subsquently  re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured  and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy. 
Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.
2.9. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
2.10. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
Page 19
Page 20
3. Other Operating Income
2025 2024
£ £
Commission income 86,223 109,147
Rental income 15,417 -
101,640 109,147
4. Operating Profit
The operating profit is stated after charging:
2025 2024
£ £
Depreciation of tangible fixed assets 155,796 126,539
5. Auditor's Remuneration
Remuneration received by the company's auditors and their associates during the year was as follows:
2025 2024
£ £
Audit Services
Audit of the company's financial statements 12,000 12,000
6. Staff Costs
Staff costs, including directors' remuneration, were as follows:
2025 2024
£ £
Wages and salaries 6,514,775 6,509,132
Social security costs 285,978 354,347
Other pension costs 57,911 65,139
6,858,664 6,928,618
7. Average Number of Employees
Average number of employees, including directors, during the year was as follows:
2025 2024
Office and administration 66 74
66 74
Page 20
Page 21
8. Directors' remuneration
2025 2024
£ £
Emoluments 235,574 249,549
Company contributions to money purchase pension schemes - 5,610
235,574 255,159
The number of directors to whom retirement benefits were accruing was as follows:
2025 2024
Money purchase pension schemes 1 1
Information regarding the highest paid director was as follows:
2025 2024
£ £
Emoluments 97,375 111,350
Company contributions to money purchase pension schemes - 5,610
97,375 116,960
9. Interest Receivable and Similar Income
2025 2024
£ £
Bank interest receivable 105,963 158,876
Investment income 1,982 2,930
107,945 161,806
10. Interest Payable and Similar Charges
2025 2024
£ £
Late payment tax charges 52 4,260
Page 21
Page 22
11. Tax on Profit
The tax charge on the profit for the year was as follows:
Tax Rate 2025 2024
2025 2024 £ £
Current tax
UK Corporation Tax 25.0% 25.0% 488,827 585,603
Deferred Tax
Deferred taxation (30,943 ) 4,479
Total tax charge for the period 457,884 590,082
The actual charge for the year can be reconciled to the expected charge for the year based on the profit and the standard rate of corporation tax as follows:
2025 2024
£ £
Profit before tax 1,872,304 2,418,465
Tax on profit at 25% (UK standard rate) 468,076 604,616
Goodwill/depreciation not allowed for tax 38,949 31,635
Capital allowances (55,742 ) (44,754 )
Short term timing differences (30,943 ) 4,479
Difference in tax rates 37,544 (5,894 )
Total tax charge for the period 457,884 590,082
12. Tangible Assets
Land & Property
Freehold Motor Vehicles Fixtures & Fittings Total
£ £ £ £
Cost
As at 1 May 2024 3,730,103 10,800 1,654,325 5,395,228
Additions 1,451,812 83,683 157,365 1,692,860
As at 30 April 2025 5,181,915 94,483 1,811,690 7,088,088
Depreciation
As at 1 May 2024 24,195 7,763 1,368,725 1,400,683
Provided during the period - 21,680 134,116 155,796
As at 30 April 2025 24,195 29,443 1,502,841 1,556,479
...CONTINUED
Page 22
Page 23
Net Book Value
As at 30 April 2025 5,157,720 65,040 308,849 5,531,609
As at 1 May 2024 3,705,908 3,037 285,600 3,994,545
13. Investments
Listed
£
Cost or Valuation
As at 1 May 2024 247,729
Disposals (247,729 )
As at 30 April 2025 -
Provision
As at 1 May 2024 -
As at 30 April 2025 -
Net Book Value
As at 30 April 2025 -
As at 1 May 2024 247,729
14. Debtors
2025 2024
£ £
Due within one year
Trade debtors 368,509 253,251
Prepayments and accrued income 113,379 116,150
Other debtors 480 480
Directors' loan accounts 1,143 1,143
483,511 371,024
15. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 150,353 102,694
Other creditors 34,496 18,005
Corporation tax 90,885 251,006
Taxation and social security 300,197 287,927
Accruals and deferred income 193,567 116,211
769,498 775,843
Page 23
Page 24
16. Deferred Taxation
The provision for deferred tax is made up as follows:
2025 2024
£ £
Other timing differences - 30,943
17. Share Capital
2025 2024
Allotted, called up and fully paid £ £
247,152 Ordinary Shares of £ 1.00 each 247,152 247,152
18. Pension Commitments
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund.
During the year the charge to the profit and loss account in respect of defined contribution schemes was £57,911 (2024: £65,139).
At the balance sheet date contributions of £NIL were due to the fund and are included in creditors.
19. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 May 2024 Amounts advanced Amounts repaid Amounts written off As at 30 April 2025
£ £ £ £ £
Mr Peter Seldon 1,143 - - - 1,143
The above loan is unsecured, interest free and repayable on demand.
20. Dividends
2025 2024
£ £
On equity shares:
Final dividend paid 2,500,000 600,000
Page 24
Page 25
21. Related Party Disclosures
Balance with related parties
The amount owed to P Seldon and C Santucci at the year end was £22,500 (2024-£13,190)
P Seldon and C Santucci
Directors
Rent paid to directors during the year was £2,167 (2024-£13,000)
P Seldon
Director
Rent paid to P Seldon during the year was £30,000 (2024-£30,000)
Page 25